Easily Transfer Your PDX Studies
Seamless Transfer of Your PDX Studies to Champions Oncology
Transferring your PDX studies does not need to compromise continuity, data integrity, or translational relevance. At Champions Oncology, we combine a structured transfer process with access to 1,400+ clinically annotated PDX models characterized by documented treatment history, multi-omic data, and detailed clinical annotation, including prior therapies received by the patient. Whether you are transitioning from another provider or consolidating programs, our team guides each step with precision. That depth of characterization is what enables an optimized study transfer.
- In Vivo Preclinical Mouse Models | Champions Oncology
- Seamless Transfer of Your PDX Studies to Champions Oncology
Why Transfer to Champions?
- Proven experience supporting study transitions with minimal downtime
- AAALAC-accredited animal care and use program, with established quality standards and animal welfare protocols
- Access to a large, well-characterized pretreated PDX bank
- Dedicated scientific and operational support from onboarding through execution
- Documented patient consent underpinning model acquisition process, delivering trusted, traceable model provenance
Our approach is designed to build confidence and ensure continuity, backed by a clear and repeatable transfer process.
A Simple 3-Step Transfer Process
We have streamlined PDX study transfers into three clear steps with defined timelines to support planning and minimize disruption.
STEP 1
Study Review & Transfer Planning
Estimated timeline: 3–5 business days
Detailed review of your current study to understand requirements and define a transfer plan. Including a review your model history, passage information, and study design; assess available data, endpoints, and timelines; identify logistics requirements and potential risks.
In partnership, we agree a clearly defined plan, including timelines, priorities, logistics, and next steps.
STEP 2
Model Establishment & Study Initiation
Estimated timeline: 2–4 weeks, dependent on logistics and modes chosen
Champions manages the safe and compliant establishment of your selected models, coordinating model logistics and expansion if required, and offering a consultation about model selection as needed.
Models are established and ready for study continuation, with full traceability and rigorous quality and animal welfare standards.
STEP 3
Study Continuation & Execution
Estimated timeline: study-specific; initiation typically within 1–2 weeks after validation
Models are established and your study resumes with confirmed protocols, aligned endpoints, in vivo/ex vivo study initiation, and ongoing data reporting and project oversight.
Benefit from seamless study continuity, consistent execution, and flexible analyses, supported by proven expertise and infrastructure.
What Makes Our Process Different
- Clarity: a straightforward three-step process removes uncertainty
- Continuity: designed to protect timelines and study integrity
- Model depth: 1,400+ models with treatment history, multi-omic and clinical data
- Quality-first approach: built on established standards and ethical practices
- Scalability: supports individual studies and large program transfers
This process is designed to be a repeatable, reliable framework for any PDX transfer scenario.
Frequently Asked Questions
How long does it take to transfer a PDX study?
Most transfers follow this general timeline: planning 3–5 business days; model establishment and validation 2–4 weeks; study restart typically within 1–2 weeks after validation. Exact timing depends on model condition, logistics, and study complexity.
Will my study need to be restarted?
In most cases, studies can continue without restarting. We aim to preserve model integrity, study design, and endpoints wherever possible. Any required adjustments will be clearly communicated upfront.
What information do I need to provide to initiate a transfer?
To get started, we typically require model details including passage history and tumor type, study design and endpoints, available data and protocols, and timeline and priority considerations. Our team will guide you through any additional requirements.
How do you ensure data continuity and integrity?
We maintain detailed documentation and full traceability throughout the transfer process. Study alignment is prioritized to ensure consistency in execution and reporting.
Can Champions support additional analyses after transfer?
Yes. Once your study is established, you can access additional capabilities such as multiomics, ex vivo platforms, and radiopharmaceutical studies, which can be integrated based on your needs.
What if I am transferring multiple models or a full program?
We support both single-study transfers and large, multi-model programs. Our process is designed to scale efficiently while maintaining consistency and quality.
Who will be my point of contact during the transfer?
You will have a dedicated scientific and operational lead who will guide you through planning, transfer, and study execution, ensuring clear communication at every step.
Get Started
If you are considering transferring your PDX studies, our team is ready to help. Contact us today to discuss your study and receive a tailored transfer plan.